Feiyan Mo

1.2k total citations
13 papers, 575 citations indexed

About

Feiyan Mo is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Feiyan Mo has authored 13 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Feiyan Mo's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (5 papers). Feiyan Mo is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (5 papers). Feiyan Mo collaborates with scholars based in United States, China and Portugal. Feiyan Mo's co-authors include Norihiro Watanabe, Mary K. McKenna, Maksim Mamonkin, Malcolm K. Brenner, Madhuwanti Srinivasan, Diogo Gomes‐Silva, Erden Atilla, Pınar Ataca Atilla, Helen E. Heslop and Haruko Tashiro and has published in prestigious journals such as Blood, Nature Biotechnology and Frontiers in Immunology.

In The Last Decade

Feiyan Mo

13 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feiyan Mo United States	11	494	203	195	192	116	13	575
Theresa Kaeuferle Germany	9	393 0.8×	207 1.0×	165 0.8×	126 0.7×	92 0.8×	15	518
Justin C. Boucher United States	12	398 0.8×	162 0.8×	254 1.3×	131 0.7×	116 1.0×	31	571
Ryo Hanajiri Japan	10	452 0.9×	162 0.8×	200 1.0×	170 0.9×	163 1.4×	29	576
Fenlu Zhu United States	9	485 1.0×	186 0.9×	146 0.7×	125 0.7×	197 1.7×	21	593
John Craddock United States	5	537 1.1×	125 0.6×	231 1.2×	230 1.2×	162 1.4×	10	646
Lisa Marie Serrano United States	8	459 0.9×	116 0.6×	268 1.4×	169 0.9×	89 0.8×	9	543
Sandhya Sharma United States	10	641 1.3×	251 1.2×	242 1.2×	261 1.4×	118 1.0×	21	735
Daniel Hollyman United Kingdom	6	321 0.6×	171 0.8×	146 0.7×	161 0.8×	72 0.6×	10	499
Paul Castillo United States	9	331 0.7×	130 0.6×	154 0.8×	100 0.5×	130 1.1×	34	462
Chunrong Tong China	11	337 0.7×	108 0.5×	113 0.6×	86 0.4×	69 0.6×	50	450

Countries citing papers authored by Feiyan Mo

Since Specialization

Citations

This map shows the geographic impact of Feiyan Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyan Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyan Mo more than expected).

Fields of papers citing papers by Feiyan Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiyan Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyan Mo. The network helps show where Feiyan Mo may publish in the future.

Co-authorship network of co-authors of Feiyan Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Feiyan Mo. A scholar is included among the top collaborators of Feiyan Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiyan Mo. Feiyan Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mo, Feiyan, Rong Zheng, Chonghui Cheng, et al.. (2024). Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis. Cytotherapy. 26(8). 858–868. 4 indexed citations

Rouce, Rayne H., et al.. (2022). Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 29(3). 165.e1–165.e7. 15 indexed citations

Watanabe, Norihiro, Feiyan Mo, & Mary K. McKenna. (2022). Impact of Manufacturing Procedures on CAR T Cell Functionality. Frontiers in Immunology. 13. 876339–876339. 115 indexed citations

Watanabe, Norihiro, Feiyan Mo, Rong Zheng, et al.. (2022). Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies. Molecular Therapy. 31(1). 24–34. 45 indexed citations

Mo, Feiyan, Norihiro Watanabe, Eiko Hayase, et al.. (2022). Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 141(10). 1194–1208. 12 indexed citations

Mo, Feiyan, Maksim Mamonkin, Malcolm K. Brenner, & Helen E. Heslop. (2021). Taking T-Cell Oncotherapy Off-the-Shelf. Trends in Immunology. 42(3). 261–272. 15 indexed citations

Atilla, Pınar Ataca, Mary K. McKenna, Haruko Tashiro, et al.. (2020). Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 8(2). e001229–e001229. 42 indexed citations

Mo, Feiyan, Norihiro Watanabe, Mary K. McKenna, et al.. (2020). Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nature Biotechnology. 39(1). 56–63. 111 indexed citations

Mo, Feiyan & Maksim Mamonkin. (2019). Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors. Methods in molecular biology. 2086. 119–130. 10 indexed citations

10.

Mo, Feiyan, Madhuwanti Srinivasan, Helen E. Heslop, Malcolm K. Brenner, & Maksim Mamonkin. (2019). Rejection-Resistant Off-the-Shelf T Cells for Adoptive Cell Therapy. Biology of Blood and Marrow Transplantation. 25(3). S168–S168. 2 indexed citations

11.

Cheng, Han, Rui Xiong, Veronica Soloveva, et al.. (2018). Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics. Antiviral Research. 157. 47–56. 23 indexed citations

12.

Gomes‐Silva, Diogo, Erden Atilla, Pınar Ataca Atilla, et al.. (2018). CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia. Molecular Therapy. 27(1). 272–280. 102 indexed citations

13.

Mamonkin, Maksim, Malini Mukherjee, Madhuwanti Srinivasan, et al.. (2017). Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunology Research. 6(1). 47–58. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact